Tokyo Tape
Sign in
← Mani

Quarterly report · Q2

7730.TEDINET S100QLQK
Period2022-09-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥12.0bn2022-09-01 → 2023-02-28Cons.Net sales
Revenue¥20.4bn2021-09-01 → 2022-08-31Cons.Net sales (5-year summary)
Revenue¥9.7bn2021-09-01 → 2022-02-28Cons.Net sales
Operating income¥3.5bn2022-09-01 → 2023-02-28Cons.Operating income
Operating income¥3.1bn2021-09-01 → 2022-02-28Cons.Operating income
Ordinary income¥3.5bn2022-09-01 → 2023-02-28Cons.Ordinary income
Ordinary income¥7.5bn2021-09-01 → 2022-08-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥3.4bn2021-09-01 → 2022-02-28Cons.Ordinary income
Profit before tax¥3.6bn2022-09-01 → 2023-02-28Cons.Income before income taxes
Profit before tax¥3.4bn2021-09-01 → 2022-02-28Cons.Income before income taxes
Net income (owners)¥2.6bn2022-09-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.3bn2021-09-01 → 2022-08-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.3bn2021-09-01 → 2022-02-28Cons.Profit loss attributable to owners of parent
Net income¥2.6bn2022-09-01 → 2023-02-28Cons.Profit loss
Net income¥2.3bn2021-09-01 → 2022-02-28Cons.Profit loss
Total assets¥50.7bnat 2023-02-28Cons.Assets
Total assets¥50.1bnat 2022-08-31Cons.Assets
Total assets¥44.3bnat 2022-02-28Cons.Total assets (5-year summary)
Total liabilities¥4.6bnat 2023-02-28Cons.Liabilities
Total liabilities¥4.7bnat 2022-08-31Cons.Liabilities
Net assets / equity¥46.2bnat 2023-02-28Cons.Net assets
Net assets / equity¥45.4bnat 2022-08-31Cons.Net assets
Net assets / equity¥41.0bnat 2022-02-28Cons.Net assets (5-year summary)
Cash and deposits¥23.4bnat 2023-02-28Cons.Cash and deposits
Cash and deposits¥22.7bnat 2022-08-31Cons.Cash and deposits
Cash & equivalents¥21.4bnat 2023-02-28Cons.Cash and cash equivalents
Cash & equivalents¥22.1bnat 2022-08-31Cons.Cash and cash equivalents
Cash & equivalents¥18.2bnat 2022-02-28Cons.Cash and cash equivalents
Cash & equivalents¥18.1bnat 2021-08-31dCons.Cash and cash equivalents
Operating cash flow¥3.8bn2022-09-01 → 2023-02-28Cons.Net cash provided by used in operating activities
Operating cash flow¥6.6bn2021-09-01 → 2022-08-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥3.0bn2021-09-01 → 2022-02-28Cons.Net cash provided by used in operating activities
Investing cash flow−¥2.6bn2022-09-01 → 2023-02-28Cons.Net cash provided by used in investment activities
Investing cash flow−¥2.2bn2021-09-01 → 2022-08-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥2.0bn2021-09-01 → 2022-02-28Cons.Net cash provided by used in investment activities
Financing cash flow−¥1.8bn2022-09-01 → 2023-02-28Cons.Net cash provided by used in financing activities
Financing cash flow−¥2.4bn2021-09-01 → 2022-08-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.2bn2021-09-01 → 2022-02-28Cons.Net cash provided by used in financing activities
EPS (basic)¥26.042022-09-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥12.842022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥53.752021-09-01 → 2022-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥23.712021-09-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥10.272021-12-01 → 2022-02-28dCons.Basic earnings loss per share (5-year summary)
Equity ratio91.0%at 2023-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio90.6%at 2022-08-31Cons.Equity to asset ratio (5-year summary)
Equity ratio92.5%at 2022-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 32
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-09-01 → 2023-02-28−¥1m
Reconciling Itemsreconcilingrevenue intersegment2022-09-01 → 2023-02-28−¥1m
jpcrp040300-q2r_E02340-000Dentalreportable segmentrevenue2022-09-01 → 2023-02-28¥4.7bn
jpcrp040300-q2r_E02340-000Dentalreportable segmentrevenue external2022-09-01 → 2023-02-28¥4.7bn
jpcrp040300-q2r_E02340-000Dentalreportable segmentsegment profit2022-09-01 → 2023-02-28¥1.3bn
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentrevenue2022-09-01 → 2023-02-28¥4.2bn
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentrevenue external2022-09-01 → 2023-02-28¥4.2bn
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentrevenue intersegment2022-09-01 → 2023-02-28¥1m
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentsegment profit2022-09-01 → 2023-02-28¥1.3bn
jpcrp040300-q2r_E02340-000Surgicalreportable segmentrevenue2022-09-01 → 2023-02-28¥3.2bn
jpcrp040300-q2r_E02340-000Surgicalreportable segmentrevenue external2022-09-01 → 2023-02-28¥3.2bn
jpcrp040300-q2r_E02340-000Surgicalreportable segmentsegment profit2022-09-01 → 2023-02-28¥917m
Total Of Reportable Segments And Otherssegment totalrevenue2022-09-01 → 2023-02-28¥12.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-09-01 → 2023-02-28¥12.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-09-01 → 2023-02-28¥1m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-09-01 → 2023-02-28¥3.5bn
Reconciling Itemsreconcilingrevenue2021-09-01 → 2022-02-28−¥2m
Reconciling Itemsreconcilingrevenue intersegment2021-09-01 → 2022-02-28−¥2m
jpcrp040300-q2r_E02340-000Dentalreportable segmentrevenue2021-09-01 → 2022-02-28¥4.0bn
jpcrp040300-q2r_E02340-000Dentalreportable segmentrevenue external2021-09-01 → 2022-02-28¥4.0bn
jpcrp040300-q2r_E02340-000Dentalreportable segmentsegment profit2021-09-01 → 2022-02-28¥1.3bn
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentrevenue2021-09-01 → 2022-02-28¥2.9bn
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentrevenue external2021-09-01 → 2022-02-28¥2.9bn
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentrevenue intersegment2021-09-01 → 2022-02-28¥2m
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentsegment profit2021-09-01 → 2022-02-28¥782m
jpcrp040300-q2r_E02340-000Surgicalreportable segmentrevenue2021-09-01 → 2022-02-28¥2.8bn
jpcrp040300-q2r_E02340-000Surgicalreportable segmentrevenue external2021-09-01 → 2022-02-28¥2.8bn
jpcrp040300-q2r_E02340-000Surgicalreportable segmentsegment profit2021-09-01 → 2022-02-28¥973m
Total Of Reportable Segments And Otherssegment totalrevenue2021-09-01 → 2022-02-28¥9.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-09-01 → 2022-02-28¥9.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-09-01 → 2022-02-28¥2m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-09-01 → 2022-02-28¥3.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 533
ItemContextValueUnit
Purchase of treasury stock fin cfPrior1YTDDuration-0JPY
Purchase of treasury stock fin cfCurrentYTDDuration－JPY
Cash dividends paid fin cfPrior1YTDDuration-1181000000JPY
Cash dividends paid fin cfCurrentYTDDuration-1771000000JPY
Amount payment of commission for syndicated loans fin cfPrior1YTDDuration-2000000JPY
Amount payment of commission for syndicated loans fin cfCurrentYTDDuration-2000000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration-1219000000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration-1826000000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration370000000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration-94000000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration148000000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration-725000000JPY
Cash and cash equivalentsPrior2YearInstant18057000000JPY
Cash and cash equivalentsPrior1YearInstant22084000000JPY
Cash and cash equivalentsPrior1QuarterInstant18205000000JPY
Cash and cash equivalentsCurrentQuarterInstant21358000000JPY
Salaries and allowances sgaPrior1YTDDuration628000000JPY
Salaries and allowances sgaCurrentYTDDuration755000000JPY
Provision for bonuses sgaPrior1YTDDuration167000000JPY
Provision for bonuses sgaCurrentYTDDuration239000000JPY
Retirement benefit expenses sgaPrior1YTDDuration29000000JPY
Retirement benefit expenses sgaCurrentYTDDuration40000000JPY
Provision for directors retirement benefits sgaPrior1YTDDuration20000000JPY
Provision for directors retirement benefits sgaCurrentYTDDuration－JPY
Research and development expenses sgaPrior1YTDDuration727000000JPY
Research and development expenses sgaCurrentYTDDuration1002000000JPY
Depreciation sgaPrior1YTDDuration146000000JPY
Depreciation sgaCurrentYTDDuration169000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E02340-000SurgicalReportableSegmentsMember2780000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E02340-000EyelessNeedleReportableSegmentsMember2857000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E02340-000DentalReportableSegmentsMember4013000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember9651000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration9651000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E02340-000SurgicalReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E02340-000EyelessNeedleReportableSegmentsMember2000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E02340-000DentalReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember2000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-2000000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E02340-000SurgicalReportableSegmentsMember2780000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E02340-000EyelessNeedleReportableSegmentsMember2859000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E02340-000DentalReportableSegmentsMember4013000000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember9653000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-2000000JPY
Net salesPrior1YTDDuration9651000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E02340-000SurgicalReportableSegmentsMember973000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E02340-000EyelessNeedleReportableSegmentsMember782000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E02340-000DentalReportableSegmentsMember1324000000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember3079000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-08-31pass rounding
balance sheet identityconsolidated 2023-02-28pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-08-31pass
statement vs summary · net assetsconsolidated 2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2021-09-01/2022-02-28pass
statement vs summary · net income attributable to parentconsolidated 2022-09-01/2023-02-28pass
statement vs summary · operating cash flowconsolidated 2021-09-01/2022-02-28pass
statement vs summary · operating cash flowconsolidated 2022-09-01/2023-02-28pass
statement vs summary · revenueconsolidated 2021-09-01/2022-02-28pass
statement vs summary · revenueconsolidated 2022-09-01/2023-02-28pass
statement vs summary · total assetsconsolidated 2022-08-31pass
statement vs summary · total assetsconsolidated 2023-02-28pass